Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 4
2012 3
2013 4
2014 5
2015 1
2016 5
2017 5
2018 4
2019 3
2020 5
2021 4
2022 8
2023 3
2024 4
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients.
Atienza-Mateo B, Serrano-Combarro A, Loarce Martos J, Vegas-Revenga N, Martín López M, Castañeda S, Melero-González RB, Mena Vázquez N, Carrasco-Cubero C, Díez Morrondo C, Castro Corredor D, Vázquez Rodríguez TR, García Valle A, Bonilla G, Rodríguez López M, Braña Abascal I, Rojas Herrera SM, Sarmiento-Monroy JC, Andújar Brazal P, Ferrer D, Ferraz-Amaro I, Blanco R; Spanish Collaborative Group of Antifibrotics in Interstitial Lung Disease Associated with Rheumatoid Arthritis. Atienza-Mateo B, et al. Semin Arthritis Rheum. 2025 Jun;72:152710. doi: 10.1016/j.semarthrit.2025.152710. Epub 2025 Mar 14. Semin Arthritis Rheum. 2025. PMID: 40117729
Ultrasound findings in palindromic rheumatism.
Sanmarti R, Ramírez J, Castellanos-Moreira R, Cabrera-Villalba SR, Ruiz-Esquide V, Salvador G. Sanmarti R, et al. Among authors: ruiz esquide v. Ann Rheum Dis. 2020 Mar;79(3):e30. doi: 10.1136/annrheumdis-2018-214832. Epub 2018 Dec 14. Ann Rheum Dis. 2020. PMID: 30552178 No abstract available.
Baricitinib in rheumatoid arthritis-interstitial lung disease: a literature review and national multicentre study of 72 patients.
Serrano-Combarro A, Atienza-Mateo B, Martín-Gutiérrez A, Loarce-Martos J, Dubuc CAE, Pastor Mena M, Melero-Gonzalez RB, Martín López M, Mena Vázquez N, Carrasco-Cubero C, Pérez García C, Valle AG, Bonilla G, Blanco Madrigal JM, Astigarraga-Urquia U, Vegas Revenga N, Albadalejo LP, Ortega Castro R, Palma-Sánchez D, Fernández Ortiz AM, Viejo PL, Lasanta ML, Garijo Bufort M, Casafont Solé I, Lamua-Riazuelo JR, Abascal IB, Ruiz-Esquide V, Cervantes Pérez EC, Flores Robles BJ, Martínez-Vidal MP, Moreno Morales J, Urruticoechea-Arana A, Rosas J, Fernández-Lozano D, Castro Corredor D, Ferraz-Amaro I, Castañeda S, Blanco R; Spanish Collaborative Group of JAKi in Interstitial Lung Disease Associated with Rheumatoid Arthritis. Serrano-Combarro A, et al. Among authors: ruiz esquide v. Rheumatology (Oxford). 2025 Oct 1;64(10):5471-5480. doi: 10.1093/rheumatology/keaf314. Rheumatology (Oxford). 2025. PMID: 40493905 Review.
Early-onset difficult-to-treat rheumatoid arthritis: proposal of data-driven predictors and temporal threshold.
Rodriguez-Merlos P, Cabrera-Alarcón JL, Ruiz-Esquide V, Chacur CA, Sanmartí R, De Miguel-Mendieta E, Álvaro-Gracia JM, Balsa A, Plasencia-Rodríguez C, Novella-Navarro M. Rodriguez-Merlos P, et al. Among authors: ruiz esquide v. Arthritis Res Ther. 2025 Jul 19;27(1):153. doi: 10.1186/s13075-025-03621-9. Arthritis Res Ther. 2025. PMID: 40684221 Free PMC article.
Vasculitic neuropathy induced by pembrolizumab.
Aya F, Ruiz-Esquide V, Viladot M, Font C, Prieto-González S, Prat A, Arance A. Aya F, et al. Among authors: ruiz esquide v. Ann Oncol. 2017 Feb 1;28(2):433-434. doi: 10.1093/annonc/mdw613. Ann Oncol. 2017. PMID: 27864214 Free article. No abstract available.
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.
Novella-Navarro M, Ruiz-Esquide V, López-Juanes N, Chacur CA, Monjo-Henry I, Nuño L, Peiteado D, Villalba A, Fernández-Fernandez E, Sanz-Jardón M, Kafati M, Sanmartí R, Plasencia-Rodríguez C, Balsa A. Novella-Navarro M, et al. Among authors: ruiz esquide v. Clin Rheumatol. 2024 Sep;43(9):2817-2823. doi: 10.1007/s10067-024-07070-8. Epub 2024 Jul 16. Clin Rheumatol. 2024. PMID: 39009920
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study.
Frade-Sosa B, Ponce A, Ruiz-Ortiz E, De Moner N, Gómara MJ, Azuaga AB, Sarmiento-Monroy JC, Morlà R, Ruiz-Esquide V, Macías L, Sapena N, Tobalina L, Ramirez J, Cañete JD, Yague J, Auge JM, Gomez-Puerta JA, Viñas O, Haro I, Sanmarti R. Frade-Sosa B, et al. Among authors: ruiz esquide v. Rheumatol Ther. 2024 Jun;11(3):501-521. doi: 10.1007/s40744-024-00650-9. Epub 2024 Mar 2. Rheumatol Ther. 2024. PMID: 38430455 Free PMC article.
Tocilizumab in the treatment of adult rheumatoid arthritis.
Sanmartí R, Ruiz-Esquide V, Bastida C, Soy D. Sanmartí R, et al. Among authors: ruiz esquide v. Immunotherapy. 2018 Mar 1;10(6):447-464. doi: 10.2217/imt-2017-0173. Epub 2018 Mar 2. Immunotherapy. 2018. PMID: 29495891 Review.
56 results